PMID:21163946

Citation	Vetterli, L, Brun, T, Giovannoni, L, Bosco, D and Maechler, P (2011) Resveratrol potentiates glucose-stimulated insulin secretion in INS-1E beta-cells and human islets through a SIRT1-dependent mechanism. J. Biol. Chem. 286:6049-60
Abstract	Resveratrol, a polyphenol compound, is known for its effects on energy homeostasis. With properties of energy sensors mediating effects of calorie restriction, sirtuins are targets of resveratrol. The mammalian sirtuin homolog SIRT1 is a protein deacetylase playing a role in glucose metabolism and islet function. Here, we investigated the effects of resveratrol and possible link with SIRT1 in β-cells. Insulinoma INS-1E cells and human islets were cultured with resveratrol before analyzing their physiological responses. Treatment of INS-1E cells for 24 h with 25 μM resveratrol resulted in marked potentiation of glucose-stimulated insulin secretion. This effect was associated with elevated glycolytic flux, resulting in increased glucose oxidation, ATP generation, and mitochondrial oxygen consumption. Such changes correlated with up-regulation of key genes for β-cell function, i.e. Glut2, glucokinase, Pdx-1, Hnf-1α, and Tfam. In human islets, chronic resveratrol treatment similarly increased both the glucose secretory response and expression of the same set of genes, eventually restoring the glucose response in islets obtained from one type 2 diabetic donor. Overexpression of Sirt1 in INS-1E cells potentiated resveratrol effects on insulin secretion. Conversely, inhibition of SIRT1 achieved either by expression of an inactive mutant or by using the EX-527 inhibitor, both abolished resveratrol effects on glucose responses. Treatment of INS-1E cells with EX-527 also prevented resveratrol-induced up-regulation of Glut2, glucokinase, Pdx-1, and Tfam. Resveratrol markedly enhanced the glucose response of INS-1E cells and human islets, even after removal of the compound from the medium. These effects were mediated by and fully dependent on active SIRT1, defining a new role for SIRT1 in the regulation of insulin secretion.
Links	PubMed PMC3057791 Online version:10.1074/jbc.M110.176842
Keywords	Animals; Carbazoles/pharmacology; Cell Line, Tumor; DNA-Binding Proteins/genetics; DNA-Binding Proteins/metabolism; Enzyme Inhibitors/pharmacology; Glucokinase/genetics; Glucokinase/metabolism; Glucose/metabolism; Glucose/pharmacology; Glucose Transporter Type 2/genetics; Glucose Transporter Type 2/metabolism; Hepatocyte Nuclear Factor 1/genetics; Hepatocyte Nuclear Factor 1/metabolism; High Mobility Group Proteins/genetics; High Mobility Group Proteins/metabolism; Homeodomain Proteins/genetics; Homeodomain Proteins/metabolism; Humans; Insulin/genetics; Insulin/secretion; Insulin-Secreting Cells/cytology; Insulin-Secreting Cells/secretion; Mitochondria/genetics; Mitochondria/metabolism; Mitochondrial Proteins/genetics; Mitochondrial Proteins/metabolism; Oxygen Consumption/drug effects; Oxygen Consumption/physiology; Rats; Sirtuin 1/antagonists & inhibitors; Sirtuin 1/genetics; Sirtuin 1/metabolism; Stilbenes/pharmacology; Trans-Activators/genetics; Trans-Activators/metabolism; Transcription Factors/genetics; Transcription Factors/metabolism; Up-Regulation/drug effects; Up-Regulation/physiology
edit table

Annotations

Gene product	Qualifier	GO Term	Evidence Code	with/from	Aspect	Extension	Notes	Status

References

See Help:References for how to manage references in GONUTS.